Naoko Miura

Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor

Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +16

Never‐smoking nonsmall cell lung cancer as a separate entity

Tokujiro Yano, Naoko Miura, Tomoyoshi Takenaka et al. · Cancer · 2008 · 146 citations

Medicine, Oncology, Oncologic Surgery +12

Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway

Takuro Kometani, Ichiro Yoshino, Naoko Miura et al. · Cancer Letters · 2009 · 71 citations

Medicine, Oncology, Pharmacology +14

Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients

Tomoyoshi Takenaka, Tokujiro Yano, Chikako Kiyohara et al. · Lung Cancer · 2009 · 69 citations

Medicine, Genetics, Molecular Genetics +11

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab

Taichi Matsubara, Shinkichi Takamori, Naoki Haratake et al. · Journal of Thoracic Disease · 2020 · 66 citations · Full text

Medicine, Immunology, Oncology +17